410 related articles for article (PubMed ID: 11244027)
1. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade.
Leenen FH; Yuan B
Hypertension; 2001 Mar; 37(3):981-4. PubMed ID: 11244027
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
3. High salt intake and the brain renin--angiotensin system in Dahl salt-sensitive rats.
Zhao X; White R; Huang BS; Van Huysse J; Leenen FH
J Hypertens; 2001 Jan; 19(1):89-98. PubMed ID: 11204309
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men.
Ribstein J; Picard A; Armagnac C; Sissmann J; Mimran A
J Cardiovasc Pharmacol; 2001 Apr; 37(4):449-60. PubMed ID: 11300658
[TBL] [Abstract][Full Text] [Related]
5. Central infusion of aliskiren prevents sympathetic hyperactivity and hypertension in Dahl salt-sensitive rats on high salt intake.
Huang BS; White RA; Bi L; Leenen FH
Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(7):R825-32. PubMed ID: 22262304
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
Lark LA; Wappel SM; Weyhenmeyer JA
J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
[TBL] [Abstract][Full Text] [Related]
7. Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist.
Ruilope L
J Hypertens Suppl; 1997 Dec; 15(7):S15-20. PubMed ID: 9532516
[TBL] [Abstract][Full Text] [Related]
8. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
10. Brain "ouabain" and angiotensin II in salt-sensitive hypertension in spontaneously hypertensive rats.
Huang BS; Leenen FH
Hypertension; 1996 Dec; 28(6):1005-12. PubMed ID: 8952589
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the AT(2)-receptor in angiotensin II-induced facilitation of sympathetic neurotransmission.
Balt JC; Mathy MJ; Nap A; Pfaffendorf M; van Zwieten PA
J Renin Angiotensin Aldosterone Syst; 2002 Sep; 3(3):181-7. PubMed ID: 12563569
[TBL] [Abstract][Full Text] [Related]
12. Both brain angiotensin II and "ouabain" contribute to sympathoexcitation and hypertension in Dahl S rats on high salt intake.
Huang BS; Leenen FH
Hypertension; 1998 Dec; 32(6):1028-33. PubMed ID: 9856968
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
Zhao X; White R; Van Huysse J; Leenen FH
J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763
[TBL] [Abstract][Full Text] [Related]
14. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects.
Schmitt F; Martinez F; Brillet G; Nguyen-Khoa T; Brouard R; Sissmann J; Lacour B; Grunfeld JP
J Cardiovasc Pharmacol; 1998 Feb; 31(2):314-21. PubMed ID: 9475275
[TBL] [Abstract][Full Text] [Related]
15. The peripheral renin-angiotensin system is not involved in the hypertension of sheep exposed to prenatal dexamethasone.
Peers A; Campbell DJ; Wintour EM; Dodic M
Clin Exp Pharmacol Physiol; 2001 Apr; 28(4):306-11. PubMed ID: 11251645
[TBL] [Abstract][Full Text] [Related]
16. Dual renin-angiotensin system blockade restores blood pressure-renin dependency in individuals with low renin concentrations.
Azizi M; Bissery A; Bura-Rivière A; Ménard J
J Hypertens; 2003 Oct; 21(10):1887-95. PubMed ID: 14508195
[TBL] [Abstract][Full Text] [Related]
17. Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.
Maillard MP; Würzner G; Nussberger J; Centeno C; Burnier M; Brunner HR
Clin Pharmacol Ther; 2002 Jan; 71(1):68-76. PubMed ID: 11823759
[TBL] [Abstract][Full Text] [Related]
18. Prevention by blockade of angiotensin subtype1-receptors of the development of genetic hypertension but not its heritability.
Madeddu P; Anania V; Varoni MV; Parpaglia PP; Demontis MP; Fattaccio MC; Palomba D; Pollock D; Glorioso N
Br J Pharmacol; 1995 Jun; 115(4):557-62. PubMed ID: 7582472
[TBL] [Abstract][Full Text] [Related]
19. Brain sodium channels mediate increases in brain "ouabain" and blood pressure in Dahl S rats.
Wang H; Leenen FH
Hypertension; 2002 Jul; 40(1):96-100. PubMed ID: 12105145
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans.
Belz GG; Butzer R; Kober S; Mutschler E
J Cardiovasc Pharmacol; 2002 Apr; 39(4):561-8. PubMed ID: 11904530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
